CJ-12420 50mg

DRUG3 trials

Sponsors

HK inno.N Corporation

Conditions

Drug InteractionHealthyNon-erosive Reflux DiseasePharmacodynamicPharmacokinetic

Phase 1

To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration

CompletedNCT03011996

HK inno.N CorporationDrug Interaction, Pharmacodynamic, Pharmacokinetic

Start: 2016-05-31End: 2017-02-28Updated: 2017-05-12

Pharmacodynamic Properties of CJ-12420 on Evening Dosing

CompletedNCT03043521

HK inno.N CorporationHealthy

Start: 2015-05-13End: 2015-08-12Updated: 2017-02-06

Phase 3

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease

CompletedNCT02556021

HK inno.N CorporationNon-erosive Reflux Disease

Start: 2015-09-22End: 2016-11-01Updated: 2018-04-04

Related Papers

Randomised clinical trial: comparison of tegoprazan and placebo in non‐erosive reflux disease

Alimentary Pharmacology & Therapeutics2021-07-0668 citations